Kevin Tan - 20 Sep 2021 Form 4 Insider Report for SELECTA BIOSCIENCES INC (RNAC)

Role
Chief Financial Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Kevin Tan
Issuer symbol
RNAC
Transactions as of
20 Sep 2021
Net transactions value
$0
Form type
4
Filing time
22 Sep 2021, 16:19:41 UTC
Next filing
06 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Employee Stock Option (right to buy) Award $0 +750,000 $0.000000 750,000 20 Sep 2021 Common Stock 750,000 $4.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest as to 25% on September 20, 2022. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.